Tivic Health Systems, Inc.
TIVC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $780 | $1,176 | $1,840 | $1,166 |
| % Growth | -33.7% | -36.1% | 57.8% | – |
| Cost of Goods Sold | $778 | $889 | $1,541 | $1,295 |
| Gross Profit | $2 | $287 | $299 | -$129 |
| % Margin | 0.3% | 24.4% | 16.3% | -11.1% |
| R&D Expenses | $1,313 | $1,655 | $1,730 | $878 |
| G&A Expenses | $3,163 | $4,752 | $5,875 | $2,929 |
| SG&A Expenses | $4,350 | $6,877 | $8,667 | $4,625 |
| Sales & Mktg Exp. | $1,187 | $2,125 | $2,792 | $1,696 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5,663 | $8,532 | $10,397 | $5,503 |
| Operating Income | -$5,661 | -$8,245 | -$10,098 | -$5,632 |
| % Margin | -725.8% | -701.1% | -548.8% | -483% |
| Other Income/Exp. Net | $6 | $1 | $2 | -$2,861 |
| Pre-Tax Income | -$5,655 | -$8,244 | -$10,096 | -$8,493 |
| Tax Expense | $0 | $0 | $0 | $1 |
| Net Income | -$5,655 | -$8,244 | -$10,096 | -$8,494 |
| % Margin | -725% | -701% | -548.7% | -728.5% |
| EPS | -19.67 | -176.72 | -104.37 | -243.16 |
| % Growth | 88.9% | -69.3% | 57.1% | – |
| EPS Diluted | -19.67 | -176.72 | -104.37 | -243.15 |
| Weighted Avg Shares Out | 287,370 | 47 | 97 | 35 |
| Weighted Avg Shares Out Dil | 287,370 | 47 | 97 | 35 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $1 | $2 | $0 |
| Interest Expense | $0 | $0 | $0 | $1,823 |
| Depreciation & Amortization | $352 | $182 | $174 | $24 |
| EBITDA | -$5,309 | -$8,062 | -$9,924 | -$6,647 |
| % Margin | -680.6% | -685.5% | -539.3% | -570.1% |